Press release
Biologics Market Top Players - Samsung BioLogics; Amgen; Novo Nordisk A/S; AbbVie Inc.; Sanofi.
Biologics Market
The Global Biologics Market is estimated to reach over USD 718.97 billion by 2031, exhibiting a CAGR of 7.50% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1729
A biological drug is a substance derived from or containing living organism components. Biologics include recombinant proteins, tissues, allergies, genes, cells, blood components, and vaccines. Biologics treat anemia, hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis, inflammatory bowel disease, and other illnesses and infections.
Numerous government initiatives, a bigger market share of biologics, increased use of biopharmaceuticals over chemically manufactured molecules, and a variety of other factors are driving the biologics market expansion throughout the projection period. Additionally, rapid developments in biotechnology have boosted biologics' phenomenal success.
Fast advances in biotechnology, funding, government efforts, and collaborations have all led to biologics' enormous success. New advances in the fields of antibody-drug conjugates, immunotherapies, and cell and gene treatments are helping to drive the biologics market forward.
List of Prominent Players in the Biologics Market:
• Abbvie Inc.
• Amgen
• AstraZeneca
• Bayer AG
• Celltrion Inc.
• Addgene
• Eli Lilly & Company
• F. Hoffmann-La Roche Ltd
• GSK group of companies
• Johnson & Johnson Services, Inc
• Merck & Co. Inc
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Precision Biologics, Inc.
• Samsung Biologics
• Sanofi
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The rising frequency and diagnosis of chronic diseases have demanded the availability of sophisticated diagnostics and treatment medications, which has fueled the worldwide biologics market. Biologics are drugs that have been genetically engineered to target a specific immune system component that causes inflammation. With the emergence of coronavirus diseases, governments all over the world are taking steps to fortify the healthcare industry and ensure the supply of biologics. Additionally, researchers and specialists are investigating species and expression systems in order to increase the production of biological products.
Challenges:
Some medications are said to have unexpected effects on immunological function, resulting in serious infections. Patients receiving biologics that impair certain immune system activities are more likely to develop a variety of opportunistic infections. This factor may impede biological therapy acceptance, negatively impacting revenue production.
Regional Trends:
The North American biologics market is expected to register a major market share in terms of revenue and is projected to develop at a high CAGR in the near future due to an increasing number of biological and technological firms, the existence of big participants in the pharmaceutical sector, and the growing prevalence of chronic sickness occurrences. In addition, ongoing efforts by regulators, policymakers, and the pharmaceutical industry to address both the affordability and availability of biologics, particularly mAbs, are expected to boost the European biologics market size in the future years.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1729
Recent Developments:
• In February 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson obtained the United States Food and Drug Administration (FDA) approval for CARVYKTI (ciltacabtagene autoleucel; cilia-cel). This drug is used to treat adults with refractory or relapsed multiple myeloma (RRMM), including an a proteasome inhibitor, immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Segmentation of Biologics Market-
By Source
• Microbial
• Mammalian
• Others
By Product
• MABs
• Vaccines
• Hormones
• Therapeutic Enzymes
• Recombinant Proteins
• Antisense, RNAi & Molecular Therapy
• Blood Factors and Anticoagulants
• Allergenic extracts
• Human Cells and Tissues
• Proteins
• Gene Therapies
• Cellular Therapies
• Others
By Disease
• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others
By Manufacturing
• Outsourced
• In-house
By Route of Administration
• Oral
• Others (IV and IP)
By Drug Classification
• Branded Drugs
• Generic Drugs
By Mode of Purchase
• Prescription Drugs
• Over-The-Counter (OTC) Drugs
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1729
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics Market Top Players - Samsung BioLogics; Amgen; Novo Nordisk A/S; AbbVie Inc.; Sanofi. here
News-ID: 3803835 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Agriculture 4.0 Market Growth Mapping and Forecast Study 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Agriculture 4.0 Market- (By Component (Hardware (Livestock Monitoring Hardware (RFID Tags and Readers, Sensors, Control Systems, GPS, Others (Drones)) Agriculture Hardware (Automation and Control Systems, Sensing and Monitoring Devices) Forestry Hardware (Harvesters & Forwarders, UAVs/ Drones, GPS, Cameras, RFID and Sensors, Variable Rate Controllers, Others) Fish Farm Hardware (GPS/ GNSS, Sensors, Others) Greenhouse Farming Hardware…
Advanced Air Mobility Market Global Demand Analysis and Forecast 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Advanced Air Mobility Market Size, Share & Trends Analysis Report By Mode of Operation (Autonomous/Remotely Operated and Pilot Operated), Propulsion Type (Turbine Engines (Turbo), Gasoline, Electric Propulsion, Hybrid Propulsion, and Reciprocating (Piston) Engines), Vehicle Type (STOL (Short Takeoff and Landing) Aircraft, EVTOL (Electric Vertical Takeoff and Landing) Aircraft, and Conventional Fixed-wing Aircraft), Application (Cargo Transport,…
Women's Digital Health Market Competitive Landscape and Outlook 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Women's Digital Health Market- by Solution Type (Single-Ended Brushes and Double-Ended Brushes), Therapeutic Application Area (Fetal Health, General Wellness, menstrual Cycle, pelvic Care, Reproductive Health/Fertility, and Other Therapeutic Application areas), Trends, Industry Competition Analysis, Revenue and Forecast To 2035."
Global Women's Digital Health Market Size is valued at USD 3.62 Billion in 2025 and is predicted…
Wearable Injectors Market Expansion Potential and Revenue Projection 2026 to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Wearable Injectors Market- (By Type of Device (Patch Pump / Injectors, Infusion Pump / Injectors), By Usability (Disposable, Reusable), By Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders, Other Disorders)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
Wearable Injectors Market Size is valued at USD 4.16 Bn in 2023 and…
More Releases for Biologics
Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top C …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad
DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by…
Platinum Biologics Highlights Rising Consumer Confusion in the Biologics Market
[Orlando, USA - March 27, 2026] - A growing wave of consumer uncertainty is reshaping how patients and buyers approach the biologics market, particularly in emerging categories such as exosomes. As interest accelerates, so does confusion-driven by inconsistent standards, complex terminology, and a flood of marketing claims that are difficult for non-experts to verify.
Recent observations shared by Platinum Biologics point to a clear behavioral shift: consumers are no longer relying…
Biologics CDMO Services Market is Booming Worldwide | Lonza Group, Catalent, Sam …
The latest study released on the Global Biologics CDMO Services Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Biologics CDMO Services study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Major…
Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
